In the Journals

Patients achieve successful outcomes after Baerveldt implantation by residents

November 14, 2019
Patients with glaucoma who underwent Baerveldt implantation by residents experienced similar outcomes and IOP reduction 1 year postoperatively when…

ELT Sight acquires excimer laser system assets from MLase

November 13, 2019
ELT Sight has acquired the IP and assets for MLase’s excimer ophthalmic laser system for glaucoma surgery, according to a press release. The…

In the Journals

Genetic variation for primary open-angle glaucoma found in those with African ancestry

November 11, 2019
Primary open-angle glaucoma may be associated with a genetic variation in individuals with African ancestry, a study found. The multicenter…

Meeting NewsVideo

VIDEO: Norlase unveils new Leaf laser

November 10, 2019
SAN FRANCISCO — At the American Academy of Ophthalmology meeting, Oliver Hvidt, CEO and co-founder of Norlase, discusses the company’s…

Netarsudil lowers IOP in Japanese phase 2 trial

November 7, 2019
A Japanese phase 2 clinical study of netarsudil ophthalmic solution showed a significant reduction in mean intraocular pressure compared with…

Proper protection, treatment can reduce severity of sports eye injuries

November 6, 2019
On the court and in the field of play, the risk for sports-related eye injuries is prevalent. Knowing how to properly treat the injuries as well as…

$7.5 million grant awarded for glaucoma research

November 6, 2019
The German state of Saxony has granted a $7.5 million grant to Mannin, a technology partner of Q BioMed Inc., to develop novel pharmaceuticals and…

Intracameral platelet-rich plasma shows efficacy for severe, chronic hypotony

Ocular Surgery News U.S. Edition, November 10, 2019
Intracameral platelet-rich plasma injected into the anterior chamber can treat cases of chronic hypotony that are nonresponsive to other treatment…


Are current technologies for spectacle-free vision an option for patients with glaucoma?

Ocular Surgery News U.S. Edition, November 10, 2019
Glaucoma patients deserve the best level of care, and this includes any new technologies that allow them to improve vision. However, it is important…

Allergan recalls certain lots of Xen 45

October 24, 2019
Allergan is voluntarily recalling certain lots of the Xen 45 glaucoma drainage device after a small number of units in an unreleased lot of the…

Meeting News

Bimatoprost SR noninferior to timolol for glaucoma treatment

October 22, 2019
SAN FRANCISCO — A study showed Bimatoprost sustained-release implant was noninferior to timolol and may potentially provide sustained IOP…


Patient type, surgeon comfort level help guide glaucoma surgery choice

Ocular Surgery News U.S. Edition, October 25, 2019
Carlos Buznego, MD; Inder Paul Singh, MD
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to…

Combination technique lowers IOP in angle-closure glaucoma

Ocular Surgery News U.S. Edition, October 25, 2019
An innovative technique combining goniosynechialysis and goniotomy achieved clinically meaningful IOP-lowering effects in patients with angle-closure…

Meeting NewsVideo

VIDEO: Bimatoprost SR shows continued IOP lowering at 1 year

October 18, 2019
SAN FRANCISCO — At the American Academy of Ophthalmology annual meeting, E. Randy Craven, MD, discusses a study showing the long-term…


VIDEO: Cataract surgery with KDB safe, effective at lowering IOP

October 16, 2019
SAN FRANCISCO — At the American Academy of Ophthalmology annual meeting, Syril K. Dorairaj, MBBS, MD, of the Mayo Clinic in Jacksonville…

FDA News

Glaukos completes enrollment in iStent infinite trial

October 11, 2019
Glaukos has completed patient enrollment in an FDA investigational device exemption trial for the iStent infinite trabecular micro-bypass system. The…

Reduced IOP maintained with two iStents at 5 years

Ocular Surgery News U.S. Edition, October 10, 2019
Patients with primary open-angle glaucoma implanted with two iStents experienced a similar IOP reduction and required fewer add-on medications…

Ocular Surgery News boosts, relaunches Healio/OSN Editorial Board Section

Ocular Surgery News U.S. Edition, October 10, 2019 is the online home of Ocular Surgery News. In addition to housing the online version of OSN, Healio/OSN creates daily news, meeting…

In the Journals

Brinzolamide may be most effective for IOP reduction after cataract surgery

October 7, 2019
Brinzolamide provided the best short-term IOP reduction after cataract surgery compared with travoprost or timolol, according to a study. The…


BLOG: Glaucoma and dry eye, part 1: Improving vision and quality of life

October 7, 2019
Glaucoma affects nearly 3 million Americans, including one in 50 people aged 40 and older. Worldwide, an estimated 76 million people will have the…